Xeris Biopharma Holdings annual operating margin
2020
2021
2022
2023
2024
2025
Xeris Biopharma Holdings Operating Margin Growth & History (XERS)
Xeris Biopharma Holdings's operating margin was 8.53% for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 8.53% | +25.10 pp |
| 2024 | 2024-12-31 | −16.57% | +10.28 pp |
| 2023 | 2023-12-31 | −26.85% | +47.47 pp |
| 2022 | 2022-12-31 | −74.32% | +157.89 pp |
| 2021 | 2021-12-31 | −232.22% | +182.30 pp |
| 2020 | 2020-12-31 | −414.52% | — |
Xeris Biopharma Holdings quarterly operating margin
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.62% | −0.65 pp |
| Q1 2026 | 2026-03-31 | 9.52% | +14.66 pp |
| Q4 2025 | 2025-12-31 | 19.55% | +16.75 pp |
| Q3 2025 | 2025-09-30 | 9.05% | +32.81 pp |
| Q2 2025 | 2025-06-30 | 6.27% | +23.30 pp |
| Q1 2025 | 2025-03-31 | −5.14% | +29.91 pp |
| Q4 2024 | 2024-12-31 | 2.79% | +12.96 pp |
| Q3 2024 | 2024-09-30 | −23.76% | +18.28 pp |
| Q2 2024 | 2024-06-30 | −17.03% | +28.51 pp |
| Q1 2024 | 2024-03-31 | −35.05% | +28.13 pp |
| Q3 2023 | 2023-09-30 | −10.17% | +64.58 pp |
| Q2 2023 | 2023-06-30 | −42.04% | +90.66 pp |
| Q4 2022 | 2022-12-31 | −45.55% | +178.21 pp |
| Q3 2022 | 2022-09-30 | −63.18% | +157.06 pp |
| Q2 2022 | 2022-06-30 | −74.75% | +214.80 pp |
| Q1 2022 | 2022-03-31 | −132.70% | +75.23 pp |
| Q4 2021 | 2021-12-31 | −223.76% | −77.61 pp |
| Q3 2021 | 2021-09-30 | −220.24% | — |
| Q2 2021 | 2021-06-30 | −289.55% | — |
| Q1 2021 | 2021-03-31 | −207.92% | — |
| Q3 2020 | 2020-09-30 | −146.15% | — |
Xeris Biopharma Holdings operating margin trends
Over the last five reported fiscal years, Xeris Biopharma Holdings's operating margin increased from −414.52% to 8.53%, a change of +423.05 percentage points. The latest reported quarter, Q2 2026, shows 5.62%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings filings at SEC.gov ↗